Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $14.52M.
ENTERPRISE VALUE (EV)
$14.52M
Lunai Bioworks Inc.
Market Cap
$5.17M
Enterprise Value (EV)
$14.52M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Lunai Bioworks Inc. (LNAI) | $5.17M | $14.52M |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.20M | $3.62M |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.21M | $3.03M |
| Alzamend Neuro Inc (ALZN)vs › | $5.32M | N/A |
| Imunon, Inc. (IMNN)vs › | $5.02M | $6.00M |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | $11.64M |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.96M | $8.37M |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.83M | $1.04M |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.54M | N/A |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.79M | $1.40M |
Market Cap
$5.17M
Total Debt
$9.44M
Cash
$92700.00
Enterprise Value
$14.52M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
